51
|
Nakagawa Y, Nakanishi Y, Tsujino I, Shimizu T, Takahashi N, Kusumi Y, Masuda S, Hashimoto S. P3.03-011 A Report of BRAF V600E Positive Lung Adenocarcinoma Patient Who Respond Well to Pemetrexed. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
52
|
Masuda S, Watanabe H, Irisa T, Hata K, Kumagai A, Tanaka C, Ozawa N, Nakashima K. Robotic anticancer drug compounding assist system for the preparation of injectable antineoplastic drugs. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx385.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
53
|
Hojo R, Fukamizu S, Miyazawa S, Nakada A, Kawamura I, Nagamine S, Masuda S, Tuchiyama T, Komiyama K, Shibui T, Nishizaki M, Sakurada H, Hiraoka M. P2662The relationship between obstructive sleep apnea and recurrence of atrial fibrillation after pulmonary vein isolation with contact-force sensing catheter. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p2662] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
54
|
Miyazawa S, Fukamizu S, Miyahara D, Inagaki D, Kawamura I, Nagamine S, Masuda S, Hojo R, Tsuchiyama T, Komiyama K, Shibui T, Nishizaki M, Sakurada H, Hiraoka M. P815Durability of pulmonary vein isolation for paroxysmal atrial fibrillation using contact force-sensing radiofrequency versus cryoballoon ablation. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx501.p815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
55
|
Murata K, Motomura Y, Tanaka T, Kanno S, Yano T, Onimaru M, Shimoyama A, Nishio H, Sakai Y, Oh-Hora M, Hara H, Fukase K, Takada H, Masuda S, Ohga S, Yamasaki S, Hara T. Calcineurin inhibitors exacerbate coronary arteritis via the MyD88 signalling pathway in a murine model of Kawasaki disease. Clin Exp Immunol 2017. [PMID: 28640392 DOI: 10.1111/cei.13002] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
Calcineurin inhibitors (CNIs) have been used off-label for the treatment of refractory Kawasaki disease (KD). However, it remains unknown whether CNIs show protective effects against the development of coronary artery lesions in KD patients. To investigate the effects of CNIs on coronary arteries and the mechanisms of their actions on coronary arteritis in a mouse model of KD, we performed experiments with FK565, a ligand of nucleotide-binding oligomerization domain-containing protein 1 (NOD1) in wild-type, severe combined immunodeficiency (SCID), caspase-associated recruitment domain 9 (CARD9)-/- and myeloid differentiation primary response gene 88 (MyD88)-/- mice. We also performed in-vitro studies with vascular and monocytic cells and vascular tissues. A histopathological analysis showed that both cyclosporin A and tacrolimus exacerbated the NOD1-mediated coronary arteritis in a dose-dependent manner. Cyclosporin A induced the exacerbation of coronary arteritis in mice only in high doses, while tacrolimus exacerbated it within the therapeutic range in humans. Similar effects were obtained in SCID and CARD9-/- mice but not in MyD88-/- mice. CNIs enhanced the expression of adhesion molecules by endothelial cells and the cytokine secretion by monocytic cells in our KD model. These data indicated that both vascular and monocytic cells were involved in the exacerbation of coronary arteritis. Activation of MyD88-dependent inflammatory signals in both vascular cells and macrophages appears to contribute to their adverse effects. Particular attention should be paid to the development of coronary artery lesions when using CNIs to treat refractory KD.
Collapse
Affiliation(s)
- K Murata
- Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Y Motomura
- Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.,Division of Molecular Immunology, Research Center for Infectious Diseases, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan
| | - T Tanaka
- Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - S Kanno
- Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - T Yano
- Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan
| | - M Onimaru
- Division of Pathophysiological and Experimental Pathology, Department of Pathology, Kyushu University, Fukuoka, Japan
| | - A Shimoyama
- Department of Chemistry, Graduate School of Science, Osaka University, Osaka, Japan
| | - H Nishio
- Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Y Sakai
- Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - M Oh-Hora
- Division of Molecular Immunology, Research Center for Infectious Diseases, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan
| | - H Hara
- Department of Immunology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
| | - K Fukase
- Department of Chemistry, Graduate School of Science, Osaka University, Osaka, Japan
| | - H Takada
- Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - S Masuda
- Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan
| | - S Ohga
- Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - S Yamasaki
- Division of Molecular Immunology, Research Center for Infectious Diseases, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan
| | - T Hara
- Division of Molecular Immunology, Research Center for Infectious Diseases, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.,Fukuoka Children's Hospital, Fukuoka, Japan
| |
Collapse
|
56
|
Kusunoki Y, Nakazawa D, Hattanda H, Miyoshi A, Shida H, Masuda S, Tomaru U, Nishio S, Atsumi T, Ishizu A. P15 THE EFFECT OF PEPTIGYLARGININE DEIMINASE 4 INHIBITOR ON MPO-ANCA PRODUCTION IN MOUSE MODEL. Kidney Int Rep 2016. [DOI: 10.1016/j.ekir.2016.09.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
57
|
Niikura N, Tomotaki A, Miyata H, Iwamoto T, Kawai M, Anan K, Hayashi N, Aogi K, Ishida T, Masuoka H, Iijima K, Masuda S, Tsugawa K, Kinoshita T, Nakamura S, Tokuda Y. Changes in tumor expression of HER2 and hormone receptors status after neoadjuvant chemotherapy in 21 755 patients from the Japanese breast cancer registry. Ann Oncol 2016; 27:480-7. [DOI: 10.1093/annonc/mdv611] [Citation(s) in RCA: 79] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2015] [Accepted: 11/28/2015] [Indexed: 12/17/2022] Open
|
58
|
Kochi M, Niikura N, Iwamoto T, Bianchini G, Mizoo T, Nogami T, Shien T, Motoki T, Taira N, Masuda S, Doihara H, Fujiwara T, Tokuda Y, Matsuoka J. Abstract P5-08-14: Tumor Infiltrating lymphocytes (TIL) related genomic signature associated with chemotherapy response and prognosis in subtypes of breast cancer. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p5-08-14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Tumor infiltrating lymphocytes (TIL) in subtypes of breast cancer may provide clinically important information on chemotherapy response and prognosis. However, the standardized methodology for immunohistochemical (IHC)-TIL has not yet been established, reproducible and objective method of evaluation of TIL such as gene expression profiles is warranted. We evaluated whether IHC-TIL level was associated with gene expression profiles and whether such profiles could be used to predict chemotherapy response and prognosis according to subtypes of breast cancers.
Methods: To select TIL associated genes, we used 40 samples with both IHC-TIL information and gene expression profiling data. The degree of TIL at the edges of the tumor mass, in the tumor mass, or in the stroma surrounding the expanding mammary ducts packed by carcinoma cells was evaluated as score 0, 1, and 2, when TIL was not unrecognizable (0%), sparse (0 << 50%) and dense (50% ≤), respectively. We selected 22 genes as the TIL-gene signature (GS), by comparing expression profiles between TIL score 2 and 0 tumors. We showed the associations between the TIL-GS levels and subtypes of breast cancers (Estrogen receptor: ER / Human Epidermal growth factor 2: HER2). The chemotherapy sensitivity analysis was performed on cohorts of 625 patients with stage I–III breast cancer who received neo adjuvant chemotherapy (NAC) based on Anthracycline and Taxane containing regimen. Data from 1,586 tumors were used to evaluate the association between distant metastasis free survival (DMFS) and the TIL-GS in a Kaplan-Meier analysis.
Results: The TIL-GS for ER negative (-)/HER2- and HER2 positive (+) cases were significantly higher expression level than luminal types (p-value <0.001). All breast cancer subtypes except luminal-low proliferation had significantly higher differential TIL-GS level in cases with pathological complete response (pCR) after NAC than residual disease (luminal-high: p-value = 0.013, HER2+: 0.005, and ER-/HER2-: 0.016). With no adjuvant chemo or only tamoxifen treated breast cancer data set, the TIL-GS had no prognostic power in luminal cases regardless of proliferative level. In HER2+ breast cancers, cases with the high TIL-GS had significantly better prognosis than low cases (p-value =0.001), but no significance in ER-/HER2- cases (p-value = 0.621).
Conclusions: Higher TIL-gene signature of 22 genes appeared to be associated with aggressive subtypes and pCR rate (except luminal-low) of breast cancers. This approach may improve the reproducibility of assessment on tumor TIL level and thus serve the clinical applications for breast cancers.
Citation Format: Kochi M, Niikura N, Iwamoto T, Bianchini G, Mizoo T, Nogami T, Shien T, Motoki T, Taira N, Masuda S, Doihara H, Fujiwara T, Tokuda Y, Matsuoka J. Tumor Infiltrating lymphocytes (TIL) related genomic signature associated with chemotherapy response and prognosis in subtypes of breast cancer. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P5-08-14.
Collapse
Affiliation(s)
- M Kochi
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan; Okayama University Hospital, Okayama, Japan; Tokai University School of Medicine, Isehara, Japan; San Raffaele Hospital, Milan, Italy; Nihon University School of Medicine, Tokyo, Japan
| | - N Niikura
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan; Okayama University Hospital, Okayama, Japan; Tokai University School of Medicine, Isehara, Japan; San Raffaele Hospital, Milan, Italy; Nihon University School of Medicine, Tokyo, Japan
| | - T Iwamoto
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan; Okayama University Hospital, Okayama, Japan; Tokai University School of Medicine, Isehara, Japan; San Raffaele Hospital, Milan, Italy; Nihon University School of Medicine, Tokyo, Japan
| | - G Bianchini
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan; Okayama University Hospital, Okayama, Japan; Tokai University School of Medicine, Isehara, Japan; San Raffaele Hospital, Milan, Italy; Nihon University School of Medicine, Tokyo, Japan
| | - T Mizoo
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan; Okayama University Hospital, Okayama, Japan; Tokai University School of Medicine, Isehara, Japan; San Raffaele Hospital, Milan, Italy; Nihon University School of Medicine, Tokyo, Japan
| | - T Nogami
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan; Okayama University Hospital, Okayama, Japan; Tokai University School of Medicine, Isehara, Japan; San Raffaele Hospital, Milan, Italy; Nihon University School of Medicine, Tokyo, Japan
| | - T Shien
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan; Okayama University Hospital, Okayama, Japan; Tokai University School of Medicine, Isehara, Japan; San Raffaele Hospital, Milan, Italy; Nihon University School of Medicine, Tokyo, Japan
| | - T Motoki
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan; Okayama University Hospital, Okayama, Japan; Tokai University School of Medicine, Isehara, Japan; San Raffaele Hospital, Milan, Italy; Nihon University School of Medicine, Tokyo, Japan
| | - N Taira
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan; Okayama University Hospital, Okayama, Japan; Tokai University School of Medicine, Isehara, Japan; San Raffaele Hospital, Milan, Italy; Nihon University School of Medicine, Tokyo, Japan
| | - S Masuda
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan; Okayama University Hospital, Okayama, Japan; Tokai University School of Medicine, Isehara, Japan; San Raffaele Hospital, Milan, Italy; Nihon University School of Medicine, Tokyo, Japan
| | - H Doihara
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan; Okayama University Hospital, Okayama, Japan; Tokai University School of Medicine, Isehara, Japan; San Raffaele Hospital, Milan, Italy; Nihon University School of Medicine, Tokyo, Japan
| | - T Fujiwara
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan; Okayama University Hospital, Okayama, Japan; Tokai University School of Medicine, Isehara, Japan; San Raffaele Hospital, Milan, Italy; Nihon University School of Medicine, Tokyo, Japan
| | - Y Tokuda
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan; Okayama University Hospital, Okayama, Japan; Tokai University School of Medicine, Isehara, Japan; San Raffaele Hospital, Milan, Italy; Nihon University School of Medicine, Tokyo, Japan
| | - J Matsuoka
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan; Okayama University Hospital, Okayama, Japan; Tokai University School of Medicine, Isehara, Japan; San Raffaele Hospital, Milan, Italy; Nihon University School of Medicine, Tokyo, Japan
| |
Collapse
|
59
|
Tang X, Yamashita T, Kumaki N, Tokuda Y, Masuda S. Abstract P1-01-09: Ductal carcinoma in situ: A comparative study between histopathological characteristics and imaging findings. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p1-01-09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The treatment policy for ductal cancer in situ (DCIS) of the breast greatly depends on the spreading diagnosis. However, a problem is that we cannot compare imaging findings with the histopathology of DCIS. The purpose of this study was to investigate the histopathological characteristics of DCIS and the association with imaging findings.
Methods: Subjects were 128 patients from Tokai University Hospital, diagnosed with DCIS. A positive finding on ultrasonography (USG) was defined as Breast Imaging Reporting and Data System (BI-RADS) of US category 3 or above, in mammography (MMG) it was Japan Breast Cancer Society category 2 or above, and in MRI it was BI-RADS-MRI category 3 or above. Histopathologically, we re-classified DCIS into 3 subtypes.
Table. Histopathological classification of the 3 DCIS subtypesSubtypesArchitectures of DCISType 1Flat and/or micropapillaryType 2Cribriform and/or papillaryType 3Solid and/or comedo, solid or comedo with any other architecture patterns, e.g. solid and cribriform or papillary, etc.
The microscopic examination items included the nuclear grade, necrosis and calcification, stromal reactions surrounding DCIS, distribution of DCIS, and with or without adenosis or other benign changes in the background breast. The automated image analysis using figures captured from virtual system are planned to evaluate concentration of DCIS distribution.
Results: 1) The clinical characteristics and association between imaging findings and histopathological classification of the 3 subtypes of DCIS are summarized as: a) Histopathologically, in type 3, there was a higher frequency of necrosis and calcification in the ducts of DCIS (χ2, p<0.001), the number of dilated peri-ductal capillaries was greater than in type 1 (p=0.023), and the distribution of DCIS was concentrated in type 3 (p=0.020); b) In imaging findings, type 3 was easier to detect than type 1 on USG (p=0.008), but there were no significant differences in MMG and MRI. 2) The 14 DCIS cases that could not be detected by USG, showed slight edematous or myxoid change in the stroma histopathologically (p<0.001), and were less likely to be detected by MRI (p=0.004). 3) The 6 MRI un-detected cases were less likely to be detected by USG (p=0.004), and the occurrence of adenosis or other benign changes in the background breast interfered with MRI (p=0.010). Peri-ductal capillaries seemed to be an important factor for MRI detection (p=0.007). 4) The results of automated image analysis will be presented.
Conclusion: USG imaging reflected the histopathological subtypes of DCIS, myxoid changes of the stroma, and the concentration of DCIS ducts. MRI was correlated with the peri-ductal capillaries of DCIS and the changes in the background breast, while MMG can make up for the shortcomings of USG and MRI. It is important for us to keep the histopathological type in mind and interpret the imaging findings comprehensively, when we do a spreading diagnosis of DCIS.
Citation Format: Tang X, Yamashita T, Kumaki N, Tokuda Y, Masuda S. Ductal carcinoma in situ: A comparative study between histopathological characteristics and imaging findings. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P1-01-09.
Collapse
Affiliation(s)
- X Tang
- Nihon-University School of Medicine, Tokyo, Japan; Tokai University, School of Medicine, Isehara, Kanagawa, Japan; Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | - T Yamashita
- Nihon-University School of Medicine, Tokyo, Japan; Tokai University, School of Medicine, Isehara, Kanagawa, Japan; Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | - N Kumaki
- Nihon-University School of Medicine, Tokyo, Japan; Tokai University, School of Medicine, Isehara, Kanagawa, Japan; Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | - Y Tokuda
- Nihon-University School of Medicine, Tokyo, Japan; Tokai University, School of Medicine, Isehara, Kanagawa, Japan; Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | - S Masuda
- Nihon-University School of Medicine, Tokyo, Japan; Tokai University, School of Medicine, Isehara, Kanagawa, Japan; Tokai University School of Medicine, Isehara, Kanagawa, Japan
| |
Collapse
|
60
|
Komaki H, Nagata T, Saito T, Masuda S, Takeshita E, Tachimori H, Sasaki M, Takeda S. Exon 53 skipping of the dystrophin gene in patients with Duchenne muscular dystrophy by systemic administration of NS-065/NCNP-01: A phase 1, dose escalation, first-in-human study. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.276] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
61
|
Faenov AY, Colgan J, Hansen SB, Zhidkov A, Pikuz TA, Nishiuchi M, Pikuz SA, Skobelev IY, Abdallah J, Sakaki H, Sagisaka A, Pirozhkov AS, Ogura K, Fukuda Y, Kanasaki M, Hasegawa N, Nishikino M, Kando M, Watanabe Y, Kawachi T, Masuda S, Hosokai T, Kodama R, Kondo K. Nonlinear increase of X-ray intensities from thin foils irradiated with a 200 TW femtosecond laser. Sci Rep 2015; 5:13436. [PMID: 26330230 PMCID: PMC4557088 DOI: 10.1038/srep13436] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2015] [Accepted: 07/27/2015] [Indexed: 11/09/2022] Open
Abstract
We report, for the first time, that the energy of femtosecond optical laser pulses, E, with relativistic intensities I > 10(21) W/cm(2) is efficiently converted to X-ray radiation, which is emitted by "hot" electron component in collision-less processes and heats the solid density plasma periphery. As shown by direct high-resolution spectroscopic measurements X-ray radiation from plasma periphery exhibits unusual non-linear growth ~E(4-5) of its power. The non-linear power growth occurs far earlier than the known regime when the radiation reaction dominates particle motion (RDR). Nevertheless, the radiation is shown to dominate the kinetics of the plasma periphery, changing in this regime (now labeled RDKR) the physical picture of the laser plasma interaction. Although in the experiments reported here we demonstrated by observation of KK hollow ions that X-ray intensities in the keV range exceeds ~10(17) W/cm(2), there is no theoretical limit of the radiation power. Therefore, such powerful X-ray sources can produce and probe exotic material states with high densities and multiple inner-shell electron excitations even for higher Z elements. Femtosecond laser-produced plasmas may thus provide unique ultra-bright X-ray sources, for future studies of matter in extreme conditions, material science studies, and radiography of biological systems.
Collapse
Affiliation(s)
- A Ya Faenov
- Institute for Academic Initiatives, Osaka University, Suita, Osaka, 565-0871, Japan.,Joint Institute for High Temperatures, Russian Academy of Sciences, Moscow 125412, Russia
| | - J Colgan
- Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA
| | - S B Hansen
- Sandia National Laboratories, Albuquerque, New Mexico 87123, USA
| | - A Zhidkov
- PPC and Graduate School of Engineering, Osaka University, 2-1, Yamadaoka, Suita, Osaka 565-0871, Japan
| | - T A Pikuz
- Joint Institute for High Temperatures, Russian Academy of Sciences, Moscow 125412, Russia.,PPC and Graduate School of Engineering, Osaka University, 2-1, Yamadaoka, Suita, Osaka 565-0871, Japan
| | - M Nishiuchi
- Quantum Beam Science Directorate, Japan Atomic Energy Agency, Kizugawa, Kyoto, Japan
| | - S A Pikuz
- Joint Institute for High Temperatures, Russian Academy of Sciences, Moscow 125412, Russia.,National Research Nuclear University (MEPhI), Moscow 115409, Russia
| | - I Yu Skobelev
- Joint Institute for High Temperatures, Russian Academy of Sciences, Moscow 125412, Russia.,National Research Nuclear University (MEPhI), Moscow 115409, Russia
| | - J Abdallah
- Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA
| | - H Sakaki
- Quantum Beam Science Directorate, Japan Atomic Energy Agency, Kizugawa, Kyoto, Japan
| | - A Sagisaka
- Quantum Beam Science Directorate, Japan Atomic Energy Agency, Kizugawa, Kyoto, Japan
| | - A S Pirozhkov
- Quantum Beam Science Directorate, Japan Atomic Energy Agency, Kizugawa, Kyoto, Japan
| | - K Ogura
- Quantum Beam Science Directorate, Japan Atomic Energy Agency, Kizugawa, Kyoto, Japan
| | - Y Fukuda
- Quantum Beam Science Directorate, Japan Atomic Energy Agency, Kizugawa, Kyoto, Japan
| | - M Kanasaki
- Quantum Beam Science Directorate, Japan Atomic Energy Agency, Kizugawa, Kyoto, Japan
| | - N Hasegawa
- Quantum Beam Science Directorate, Japan Atomic Energy Agency, Kizugawa, Kyoto, Japan
| | - M Nishikino
- Quantum Beam Science Directorate, Japan Atomic Energy Agency, Kizugawa, Kyoto, Japan
| | - M Kando
- Quantum Beam Science Directorate, Japan Atomic Energy Agency, Kizugawa, Kyoto, Japan
| | - Y Watanabe
- Interdisciplinary Graduate School of Engineering Sciences, Kyushu University, Japan
| | - T Kawachi
- Quantum Beam Science Directorate, Japan Atomic Energy Agency, Kizugawa, Kyoto, Japan
| | - S Masuda
- PPC and Graduate School of Engineering, Osaka University, 2-1, Yamadaoka, Suita, Osaka 565-0871, Japan
| | - T Hosokai
- PPC and Graduate School of Engineering, Osaka University, 2-1, Yamadaoka, Suita, Osaka 565-0871, Japan
| | - R Kodama
- Institute for Academic Initiatives, Osaka University, Suita, Osaka, 565-0871, Japan.,PPC and Graduate School of Engineering, Osaka University, 2-1, Yamadaoka, Suita, Osaka 565-0871, Japan
| | - K Kondo
- Quantum Beam Science Directorate, Japan Atomic Energy Agency, Kizugawa, Kyoto, Japan
| |
Collapse
|
62
|
Okano T, Tsugawa N, Masuda S, Takeuchi A, Kobayashi T, Nishii Y. A novel synthetic vitamin D3 analogue, 2-beta-(3-hydroxypropoxy)-calcitriol (ED-71): its biological activities and pharmacological effects on calcium metabolism. Contrib Nephrol 2015; 91:116-22. [PMID: 1800002 DOI: 10.1159/000420166] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
A novel vitamin D3 analogue, [2 beta-(3-hydroxypropoxy)-calcitriol: ED-71] showed a similar Ca-regulating activity as calcitriol in the in vivo and in vitro Ca mobilization test and ex vivo intestinal Ca absorption assay using vitamin D-deficient rats. The differentiation-inducing activity of ED-71 in mouse myeloid leukemia cell line (WEHI-3 cell) was slightly less than that of calcitriol. ED-71 distributes predominantly in plasma as an intact form and its half-life plasma was twice as long as that of calcitriol. Further study revealed that the higher binding potency of ED-71 to plasma-specific vitamin D-binding protein (DBP) compared with that of calcitriol accounts for its stability in the blood circulation. The pharmacological effect of ED-71 for the animal models with osteoporosis seemed to be better than that calcitriol. These results suggest that ED-71 should become a valuable therapeutic long-acting drug for patients with osteoporosis.
Collapse
Affiliation(s)
- T Okano
- Department of Hygienic Sciences, Kobe Women's College of Pharmacy, Japan
| | | | | | | | | | | |
Collapse
|
63
|
Abstract
The binding potencies of OCT to chick intestinal calcitriol receptor and vitamin DBP were approximately 1/8 and 1/600 of the respective values of calcitriol. OCT is circulating mainly as an intact form bound to chylomicrons and/or lipoproteins. Intravenously injected [3H]-OCT to normal rats was quickly decreased from blood and rapid excretion of OCT as a glucuronate into bile was observed. However, significant amounts of radioactivities were recovered in the intact form in liver and intestine even after 24 h. The separation of calcemic and immune and/or differentiation activities may be derived from the rapid turnover and the nonspecific transporting system.
Collapse
Affiliation(s)
- T Kobayashi
- Department of Hygienic Sciences, Kobe Women's College of Pharmacy, Japan
| | | | | | | | | | | |
Collapse
|
64
|
Zhang C, McFarlane C, Lokireddy S, Bonala S, Ge X, Masuda S, Gluckman PD, Sharma M, Kambadur R. Erratum to: 'Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice' and 'Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway'. Diabetologia 2015; 58:643. [PMID: 25500699 DOI: 10.1007/s00125-014-3450-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
- C Zhang
- Department of Genomics and Genetics, School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Republic of Singapore
| | | | | | | | | | | | | | | | | |
Collapse
|
65
|
Hashi S, Masuda S, Kikuchi M, Uesugi M, Yano I, Omura T, Yonezawa A, Fujimoto Y, Ogawa K, Kaido T, Uemoto S, Matsubara K. Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients. Transplant Proc 2015; 46:758-60. [PMID: 24767342 DOI: 10.1016/j.transproceed.2013.11.060] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2013] [Accepted: 11/22/2013] [Indexed: 10/25/2022]
Abstract
Therapeutic drug monitoring (TDM) and subsequent dosage adjustment for individual patients in the treatment with tacrolimus are required after liver transplantation to prevent rejection and over-immunosuppression, which leads to severe infection and adverse reactions including nephrotoxicity. The purpose of this study was to evaluate the analytical performance among commercially available immunoassay methods, which were microparticle enzyme immunoassay (MEIA), chemiluminescent enzyme immunoassay (CLIA), and affinity column-mediated immunoassay (ACMIA), compared with an assay using liquid chromatography-tandem mass spectrometry (LC-MS/MS). In addition, the flow injection assay (FIA-MS/MS) was also evaluated to determine whether it could be available as a new method of analysis in tacrolimus therapy. The blood tacrolimus concentrations in samples from liver transplant recipients (n = 102) were measured using MEIA, CLIA, ACMIA, and LC-MS/MS. Additional blood samples from liver transplant recipients (n = 54) were analyzed using both FIA-MS/MS and LC-MS/MS. Because the assay performance and characteristics of MEIA, CLIA, ACMIA, and FIA-MS/MS are relatively different, the measured data should be carefully considered depending on the methodology.
Collapse
Affiliation(s)
- S Hashi
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan
| | - S Masuda
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan
| | - M Kikuchi
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan
| | - M Uesugi
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan
| | - I Yano
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan; Department of Clinical Pharmacy and Education, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - T Omura
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan
| | - A Yonezawa
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan
| | - Y Fujimoto
- Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - K Ogawa
- Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - T Kaido
- Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - S Uemoto
- Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - K Matsubara
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.
| |
Collapse
|
66
|
Maw AA, Kawabe K, Shimogiri T, Rerkamnuaychoke W, Kawamoto Y, Masuda S, Okamoto S. Genetic diversity and population structure in native chicken populations from myanmar, Thailand and laos by using 102 indels markers. Asian-Australas J Anim Sci 2015; 28:14-9. [PMID: 25557671 PMCID: PMC4283183 DOI: 10.5713/ajas.14.0212] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/24/2014] [Revised: 06/05/2014] [Accepted: 07/08/2014] [Indexed: 11/27/2022]
Abstract
The genetic diversity of native chicken populations from Myanmar, Thailand, and Laos was examined by using 102 insertion and/or deletion (indels) markers. Most of the indels loci were polymorphic (71% to 96%), and the genetic variability was similar in all populations. The average observed heterozygosities (HO) and expected heterozygosities (HE) ranged from 0.205 to 0.263 and 0.239 to 0.381, respectively. The coefficients of genetic differentiation (Gst) for all cumulated populations was 0.125, and the Thai native chickens showed higher Gst (0.088) than Myanmar (0.041) and Laotian (0.024) populations. The pairwise Fst distances ranged from 0.144 to 0.308 among populations. A neighbor-joining (NJ) tree, using Nei’s genetic distance, revealed that Thai and Laotian native chicken populations were genetically close, while Myanmar native chickens were distant from the others. The native chickens from these three countries were thought to be descended from three different origins (K = 3) from STRUCTURE analysis. Genetic admixture was observed in Thai and Laotian native chickens, while admixture was absent in Myanmar native chickens.
Collapse
Affiliation(s)
- A A Maw
- University of Veterinary Science, Yezin, Nay Pyi Taw 05282, Myanmar ; Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan
| | - K Kawabe
- Natural Science Centre for Research and Education, Kagoshima University, Kagoshima 890-0065, Japan
| | - T Shimogiri
- Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan
| | - W Rerkamnuaychoke
- Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand
| | - Y Kawamoto
- Faculty of Agriculture, University of Ryukyus, Nishihara 903-0213, Japan
| | - S Masuda
- Liberal Arts Education Centre, Aso Campus, Tokai University, Minami Aso-mura 869-1404, Japan
| | - S Okamoto
- Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan
| |
Collapse
|
67
|
Muto M, Mori M, Sato Y, Uzawa A, Masuda S, Uchida T, Kuwabara S. Current symptomatology in multiple sclerosis and neuromyelitis optica. Eur J Neurol 2014; 22:299-304. [DOI: 10.1111/ene.12566] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2014] [Accepted: 07/25/2014] [Indexed: 01/18/2023]
Affiliation(s)
- M. Muto
- Department of Neurology; Graduate School of Medicine; Chiba University; Chiba Japan
| | - M. Mori
- Department of Neurology; Graduate School of Medicine; Chiba University; Chiba Japan
| | - Y. Sato
- Clinical Research Center; Chiba University Hospital; Chiba Japan
| | - A. Uzawa
- Department of Neurology; Graduate School of Medicine; Chiba University; Chiba Japan
| | - S. Masuda
- Department of Neurology; Graduate School of Medicine; Chiba University; Chiba Japan
| | - T. Uchida
- Department of Neurology; Graduate School of Medicine; Chiba University; Chiba Japan
| | - S. Kuwabara
- Department of Neurology; Graduate School of Medicine; Chiba University; Chiba Japan
| |
Collapse
|
68
|
Shimura H, Masuda S, Kimura H. Research and development productivity map: visualization of industry status. J Clin Pharm Ther 2014; 39:175-80. [DOI: 10.1111/jcpt.12126] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2013] [Accepted: 12/09/2013] [Indexed: 01/23/2023]
Affiliation(s)
- H. Shimura
- Pharmaco-Business Innovation Laboratory; Graduate School of Pharmaceutical Sciences; The University of Tokyo; Tokyo Japan
| | - S. Masuda
- Pharmaco-Business Innovation Laboratory; Graduate School of Pharmaceutical Sciences; The University of Tokyo; Tokyo Japan
| | - H. Kimura
- Pharmaco-Business Innovation Laboratory; Graduate School of Pharmaceutical Sciences; The University of Tokyo; Tokyo Japan
| |
Collapse
|
69
|
Mori M, Muto M, Hiwasa T, Uzawa A, Masuda S, Uchida T, Masuda H, Kuwabara S. Identification of novel candidate autoantigens in multiple sclerosis by expression cloning. J Neurol Sci 2013. [DOI: 10.1016/j.jns.2013.07.1424] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
70
|
Uzawa A, Mori M, Taniguchi J, Masuda S, Muto M, Kuwabara S. Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis. Clin Exp Immunol 2013; 172:37-43. [PMID: 23480183 DOI: 10.1111/cei.12036] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/08/2012] [Indexed: 12/31/2022] Open
Abstract
High mobility group box 1 (HMGB1) is an established inflammatory mediator when released from cells. Recent studies have implicated extracellular HMGB1 in the pathogenesis of various autoimmune diseases. The objective of this study was to determine whether HMGB1 could be a therapeutic target for experimental autoimmune encephalomyelitis (EAE). In this study, an anti-HMGB1 monoclonal antibody was injected intraperitoneally into a mouse model of EAE. We also measured serum cytokines levels in EAE and anti-HMGB1 monoclonal antibody-treated EAE. As a result, intraperitoneal injection of an anti-HMGB1 monoclonal antibody ameliorated the clinical and pathological severity of EAE and attenuated interleukin-17 up-regulation in serum. In conclusion, HMGB1 is involved in EAE pathogenesis and could trigger inflammation in the central nervous system. The novel aspect of this study is the demonstration that anti-HMGB1 ameliorates EAE. HMGB1 may be a novel therapeutic strategy for multiple sclerosis.
Collapse
Affiliation(s)
- A Uzawa
- Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
| | | | | | | | | | | |
Collapse
|
71
|
Masuda S, Shoji H. Development of a submerged culture method for high production of acid- stable α-amylase and glucoamylase usingAspergillus kawachiiwithout glucose concentration control. J Inst Brew 2013. [DOI: 10.1002/jib.53] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- S. Masuda
- Research and Development Laboratories for Brewing; Asahi Breweries Ltd; 1-21 Midori, 1-Chome Moriya-Shi 302-0106 Ibaraki Japan
| | - H. Shoji
- Research and Development Laboratories for Brewing; Asahi Breweries Ltd; 1-21 Midori, 1-Chome Moriya-Shi 302-0106 Ibaraki Japan
| |
Collapse
|
72
|
Kido T, Sakakibara H, Ohura T, Guruge KS, Kojima M, Hasegawa J, Iwamura T, Yamanaka N, Masuda S, Sakaguchi M, Amagai T, Shimoi K. Evaluation of chlorinated benz[a]anthracene on hepatic toxicity in rats and mutagenic activity in Salmonella typhimurium. Environ Toxicol 2013; 28:21-30. [PMID: 21384493 DOI: 10.1002/tox.20693] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/06/2010] [Revised: 12/13/2010] [Accepted: 12/18/2010] [Indexed: 05/30/2023]
Abstract
Chlorinated benz[a]anthracenes (Cl-BaA) are halogenated aromatic compounds (typified by dioxins) found in the environment at relatively high concentrations. Fischer 344 rats were intragastrically administered 0, 1, or 10 mg of Cl-BaA or its parent compound benz[a]anthracene (BaA) per kg of body weight for 14 consecutive days. Both chemicals at 10 mg/kg/day inhibited the gain in body weight, and consequent increase in relative liver weight. Hepatic gene expression of cytochrome P450 (CYP) 1A1, 1A2, and 1B1 was significantly stimulated by administration of BaA (10 mg/kg/day) compared with the control. After administration of Cl-BaA, only the CYP1A2 gene was significantly induced, even at the lower dosage; CYP1A1 and 1B1 mRNA levels remained unchanged in Cl-BaA-treated rats compared with controls. To elucidate the role of such Cl-BaA exposure and induced CYPs at toxicity onset, we investigated the mutagenicity of BaA and Cl-BaA using Salmonella typhimurium TA98 and TA100. BaA and Cl-BaA at 10 μg/plate produced positive results in both strains in the presence of rat S-9. Incubation of Cl-BaA with recombinant rat CYP1A2 produced a significantly higher number of revertant colonies in TA98 and TA100 than in controls, but no such change was observed for BaA. In conclusion, BaA changes its own physiological and toxicological actions by its chlorination; (1) daily exposure to Cl-BaA selectively induces hepatic CYP1A2 in rats and (2) Cl-BaA induces frameshift mutations in the presence of CYP1A2, although BaA does not exert mutagenicity. This indicates that CYP1A2 may metabolize Cl-BaA to active forms.
Collapse
Affiliation(s)
- T Kido
- Graduate School of Nutritional and Environmental Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
73
|
Ueno T, Mikami Y, Yoshimura K, Tsuda H, Kurosumi M, Masuda S, Horii R, Toi M, Sasano H. Abstract P5-01-02: Inter-observer concordance of Ki-67 labeling index in breast cancer: Japan Breast Cancer Research Group (JBCRG) Ki-67 Ring Study. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p5-01-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The standardized assessment of Ki-67 labeling index (LI) plays pivotal roles in identifying the patients (pts) with primary breast cancer who could benefit from systemic chemotherapy, in particular among pts with estrogen receptor(ER)-positive cancers. Therefore, in this study, we evaluated the inter-observer concordance of the assessment of Ki-67 LI in archival materials.
Methods: Six surgical pathologists specializing in breast pathology from different Japanese institutions participated in this study. All slides were prepared from archival tissues of breast cancer fixed in 10% buffered formalin for 24 hours in a single institution (KU). Three independent studies were conducted. Study 1) Six consecutive slides were prepared from 5 cases. A slide from each case was stained with MIB-1 (DAKO, Denmark) in each institution according to their routine methods. Total of 30 stained slides were assessed for Ki-67 LI by each pathologist using two different modes of assessment. One is the scoring system in which the rate of positive cells was scored from 1 (0–9 %) to 10 (90–100%) without counting the cell number. The second one is the counting system in which approximately 1000 cells in total were counted in the hot spots and the positive rate was calculated. Study 2) Twenty tumors with Ki-67 LI ranging from 5 to 25 (15 ± 10) %, stained in a single institution (KU) were assessed by each pathologist by the counting system. Study 3) In order to avoid variations by assessment in varied microscopic fields and to further evaluate the variation of threshold of immunointensity interpreted as positive by different pathologists, fifteen printed photographs of Ki-67-stained slides were sent and assessed for Ki-67 LI by each participating breast pathologist.
Results: Study 1) The counting system demonstrated a better correlation of Ki-67 LI among six pathologists than the scoring system {the intraclass correlation coefficient (ICC), 0.66 (95% confidence interval 0.52–0.78) for the counting system, 0.57 (0.42–0.72) for the scoring system}. The two assessment systems showed a moderate correlation {ICC, 0.68 (0.60–0.75)}. Study 2) The assessment of Ki-67 LI in 20 slides with Ki-67 LI of 5 to 25 % demonstrated a correlation similar to that in the specimens with an unrestricted range of Ki-67 LI in the study 1 {ICC, 0.68 (0.50–0.81) for the study 2, 0.66 (0.52–0.78) for the study 1}. Study 3) The assessment of Ki-67 LI in the same photographs yielded a considerably significant concordance among six pathologists {ICC, 0.94 (0.88–0.97)}.
Conclusion: The counting system turned out better than the scoring system in terms of the inter-observer agreement of the Ki-67 LI assessment. The degree of concordance was by no means influenced by the range of Ki-67 LI. The concordance of the Ki-67 LI assessment among six participating pathologists was significantly high when the assessed field was fixed using the same photographs for evaluation, suggesting that the selection of the fields for evaluation is critical. These results suggest that identification of hot spots for evaluation is pivotal for obtaining the accurate Ki-67 LI of breast cancer and still images of these hot spots could provide reproducible results.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P5-01-02.
Collapse
Affiliation(s)
- T Ueno
- Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Saitama Cancer Center, Saitama, Japan; Nihon University School of Medicine, Tokyo, Japan; The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; Tohoku University School of Medicine, Sendai, Japan
| | - Y Mikami
- Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Saitama Cancer Center, Saitama, Japan; Nihon University School of Medicine, Tokyo, Japan; The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; Tohoku University School of Medicine, Sendai, Japan
| | - K Yoshimura
- Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Saitama Cancer Center, Saitama, Japan; Nihon University School of Medicine, Tokyo, Japan; The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; Tohoku University School of Medicine, Sendai, Japan
| | - H Tsuda
- Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Saitama Cancer Center, Saitama, Japan; Nihon University School of Medicine, Tokyo, Japan; The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; Tohoku University School of Medicine, Sendai, Japan
| | - M Kurosumi
- Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Saitama Cancer Center, Saitama, Japan; Nihon University School of Medicine, Tokyo, Japan; The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; Tohoku University School of Medicine, Sendai, Japan
| | - S Masuda
- Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Saitama Cancer Center, Saitama, Japan; Nihon University School of Medicine, Tokyo, Japan; The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; Tohoku University School of Medicine, Sendai, Japan
| | - R Horii
- Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Saitama Cancer Center, Saitama, Japan; Nihon University School of Medicine, Tokyo, Japan; The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; Tohoku University School of Medicine, Sendai, Japan
| | - M Toi
- Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Saitama Cancer Center, Saitama, Japan; Nihon University School of Medicine, Tokyo, Japan; The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; Tohoku University School of Medicine, Sendai, Japan
| | - H Sasano
- Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Saitama Cancer Center, Saitama, Japan; Nihon University School of Medicine, Tokyo, Japan; The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; Tohoku University School of Medicine, Sendai, Japan
| |
Collapse
|
74
|
Abstract
WHAT IS KNOWN AND OBJECTIVE The increasing cost of drug research and development and the decreasing number of new drugs being launched are serious issues for pharmaceutical companies. Biomarkers for predicting drug effectiveness are regarded as useful tools for combating these trends. However, the extent to which these biomarkers actually help in improving drug development is unclear. Here, we investigated the efficiency of biomarker usage in oncology drug development by focusing on stratification markers. METHODS Anti-tumour agents for which clinical studies were initiated between 1998 and 2009 were identified using commercially available data sources, and clinical trials registered in ClinicalTrials.gov were examined to identify the use of stratification marker. Phase transition probability for each clinical phase was calculated and analysed along with various other factors that may affect the efficiency of the development process. RESULTS AND DISCUSSION Of 908 anti-tumour agents identified, 121 (13·3%) utilized stratification markers in their clinical studies. Phase I, II and III transition probabilities for all agents were 76·4%, 50·8% and 58·5%, respectively. Corresponding Phase I, II and III transition probabilities of agents developed with stratification markers of 90·4%, 69·0% and 85·0%, respectively, were significantly higher than those for agents without stratification markers. Orphan designation positively affected phase transition probabilities of agents without stratification markers in all phases, while it did not affect transition probabilities of agents with stratification markers, except for Phase II. This shows that stratification markers help improve the probability of success in the development of agents without orphan designation. WHAT IS NEW AND CONCLUSION Stratification markers contribute to improving the efficiency of development of anti-cancer drugs. The majority of non-orphan drugs are still being developed without stratification markers. Finding reliable stratification markers for all drugs should improve the success rates in drug development.
Collapse
Affiliation(s)
- K Hayashi
- Pharmaco-Business Innovation Laboratory, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
| | | | | |
Collapse
|
75
|
Toyama K, Yonezawa A, Masuda S, Osawa R, Hosokawa M, Fujimoto S, Inagaki N, Inui K, Katsura T. Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin-induced lactic acidosis. Br J Pharmacol 2012; 166:1183-91. [PMID: 22242910 DOI: 10.1111/j.1476-5381.2012.01853.x] [Citation(s) in RCA: 57] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
BACKGROUNDS AND PURPOSE Lactic acidosis is a fatal adverse effect of metformin, but the risk factor remains unclear. Multidrug and toxin extrusion 1 (MATE1) is expressed in the luminal membrane of the kidney and liver. MATE1 was revealed to be responsible for the tubular and biliary secretion of metformin. Therefore, some MATE polymorphisms, that cause it to function abnormally, are hypothesized to induce lactic acidosis. The purpose of this study is to clarify the association between MATE dysfunction and metformin-induced lactic acidosis. EXPERIMENTAL APPROACH Blood lactate, pH and bicarbonate ion (HCO(3) (-) ) levels were evaluated during continuous administration of 3 mg·mL(-1) metformin in drinking water using Mate1 knockout (-/-), heterozygous (+/-) and wild-type (+/+) mice. To determine the tissue accumulation of metformin, mice were given 400 mg·kg(-1) metformin orally. Furthermore, blood lactate data were obtained from diabetic patients given metformin. KEY RESULTS Seven days after metformin administration in drinking water, significantly higher blood lactate, lower pH and HCO(3) (-) levels were observed in Mate1(-/-) mice, but not in Mate1(+/-) mice. The blood lactate levels were not affected in patients with the heterozygous MATE variant (MATE1-L125F, MATE1-G64D, MATE2-K-G211V). Sixty minutes after metformin administration (400 mg·kg(-1) , p.o.) the hepatic concentration of metformin was markedly higher in Mate1(-/-) mice than in Mate1(+/+) mice. CONCLUSION AND IMPLICATIONS MATE1 dysfunction caused a marked elevation in the metformin concentration in the liver and led to lactic acidosis, suggesting that the homozygous MATE1 variant could be one of the risk factors for metformin-induced lactic acidosis.
Collapse
Affiliation(s)
- K Toyama
- Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Kyoto, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
76
|
Shirai Y, Inagaki M, Yamaguchi M, Kambe T, Nagao M, Masuda S, Sasaki R. Effect of hypoxia duration on the oxygen-dependent production of a recombinant protein, β-galactosidase, by an animal cell line, F6D2, with a hypoxia-inducible enhancer. Cytotechnology 2012; 25:71-7. [PMID: 22358881 DOI: 10.1023/a:1007911816292] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Expression of specific genes is a strategy of animal cells for adaptation to oxygen deficiency and the mechanism underlying the hypoxic activation of gene expression may be useful for efficient production of recombinant proteins by animal cells, because oxygen is a limiting factor in animal cell cultures. We prepared an animal cell line harboring the plasmid in which expression of a reporter gene, β-galactosidase, is controlled by an enhancer responsible for the hypoxic activation of gene transcription. The purpose of this paper is to understand this hypoxic production of recombinant proteins quantitatively by a mathematical model originally developed based on the following hypotheses; 1 lacZ (the reporter gene) is transcribed after HIF-1 protein complex is bound to the hypoxic enhancer, 2. β-galactosidase synthesis rate is limited at the transcription of lacZ, 3. HIF-1 is an inactive form under a normal oxygen concentration, 4. Oxygen works as a repressor in the synthesis of HIF-1 protein, 5. Both β-galactosidase and HIF-1 are decomposed according to the first order reaction. The effects of hypoxic duration as well as oxygen concentration on the β-galactosidase production were successfully predicated by the model.
Collapse
|
77
|
Masuda S, Kada E, Nagao M, Sasaki R. In vitro neuroprotective action of recombinant rat erythropoietin produced by astrocyte cell lines and comparative studies with erythropoietin produced by Chinese hamster ovary cells. Cytotechnology 2012; 31:179-84. [PMID: 19003139 DOI: 10.1023/a:1008028423510] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
In the central nervous system, astrocytes produce erythropoietin (Epo) and neurons express its receptor. To examine whether or not the brain Epo protects the in vitro cultured neurons from glutamate-induced cell death, we established rat astrocyte cell lines containing the plasmid for production of recombinant rat Epo. Epo partially purified from the culture medium showed a neuroprotective effect similar to that of rat Epo produced by Chinese hamster ovary (CHO) cells. Comparison was made in some other properties between Epo produced by these astrocyte cell lines and that by CHO cells.
Collapse
|
78
|
Shinagawa R, Masuda S, Sasaki R, Ikura K, Takahata K. In vitro neurotoxicity of amyloid β-peptide cross-linked by transglutaminase. Cytotechnology 2012; 23:77-85. [PMID: 22358523 DOI: 10.1023/a:1007999114779] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
UNLABELLED Transglutaminase catalyzes the intermolecular cross-linking of peptides between Gln and Lys residues, forming an ε-(γ-glutamyl) lysine bond. Amyloid β-peptide, a major constituent of the deposits in Alzheimer disease, contains Lys16, Lys28, and Gln15 which may act as substrates of transglutaminase. Transglutaminase treatment of amyloid β-peptide (1-28) and amyloid β-peptide (1-40) yielded cross-linked oligomers. Transglutaminase-treated Aβ retarded neurite extension of PC12 cells, and rat cultured neurons of hippocampus and septum, brain areas severely affected by Alzheimer disease, and subsequently caused cell death, whereas the transglutaminase-untreated counterparts did not show harmful effects. The transglutaminase-catalyzed oligomers of amyloid β-peptide and their neurotoxicity may be involved in two characteristics in Alzheimer disease, neuronal degeneration and formation of the insoluble deposits. ABBREVIATIONS AD - Alzheimer disease, Aβ - amyloid β-peptide, DMEM - Dulbecco's modified Eagle's medium, DMEM/F-12-1:1 mixture of DMEM and Ham's F-12 medium, FCS - fetal calf serum, HS - horse serum, PAGE - polyacrylamide gel electrophoresis, MTT - 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, NGF - nerve growth factor, TGase - transglutaminase.
Collapse
Affiliation(s)
- R Shinagawa
- Department of Food Science and Technology, Faculty of Agriculture, Kyoto University, Kyoto, 606-01, Japan
| | | | | | | | | |
Collapse
|
79
|
Moon SK, Takeuchi S, Kambe T, Tsuchiya T, Masuda S, Nagao M, Sasaki R. Erythropoietin enhancer stimulates production of a recombinant protein by Chinese hamster ovary (CHO) cells under hypoxic condition. Cytotechnology 2012; 25:79-88. [PMID: 22358882 DOI: 10.1023/a:1007963800362] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Oxygen is a limiting nutrient in animal cell culture and its supply is still worthy of improvement for production of useful proteins with a high efficiency. From a different point of view, development of the system by which a high productivity can be maintained even under hypoxic condition as well as under normoxic condition may be important. A number of hypoxia-inducible genes have been found in eucaryotic cells and the induction in most cases, if not all, is due to hypoxic activation of the gene transcription. Transcription of erythropoietin gene is highly hypoxia-inducible and the induction is achieved by binding of a protein, which is widely distributed in animal cells, to a short DNA stretch (erythropoietin enhancer) in the 3' flanking region of erythropoietin gene. Using a hepatoma cell line (Hep3B) that produces the endogenous erythropoietin in an oxygen-dependent manner and Chinese hamster ovary cells that have been widely used for production of recombinant proteins, we show that, under hypoxic condition, the erythropoietin enhancer can activate not only the promoter of erythropoietin gene but also promoters of cytomegalovirus early genes and eucaryotic polypeptide chain elongation factor gene, both of which are very active in animal cells under normoxic condition.
Collapse
|
80
|
Niikura N, Masuda S, Terada M, Terao M, Kumaki N, Oshitanai R, Morioka T, Tsuda B, Okamura T, Saito Y, Suzuki Y, Tokuda Y. Prognostic Factor KI67 for Breast Cancer Patients in Each Subgroup. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)32364-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
81
|
Niikura N, Iwamoto T, Masuda S, Kumaki N, Shirane M, Mori K, Okamura T, Saito Y, Suzuki Y, Tokuda Y. Immunohistochemical Ki67 Labeling Index has a Similar Proliferation Predictive Power as Various First-Generation Gene Signatures in Breast Cancer. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)32870-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
82
|
Yoshitoshi EY, Yoshizawa A, Ogawa E, Kaneshiro M, Takada N, Okamoto S, Fujimoto Y, Sakamoto S, Masuda S, Matsuura M, Nakase H, Chiba T, Tsuruyama T, Haga H, Uemoto S, Uemoto S. The challenge of acute rejection in intestinal transplantation. Pediatr Surg Int 2012; 28:855-9. [PMID: 22760434 DOI: 10.1007/s00383-012-3110-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 05/30/2012] [Indexed: 10/28/2022]
Abstract
Early diagnosis and treatment of acute cellular rejection (ACR) after intestinal transplantation (ITx) is challenging. We report the outcome of three patients: two presented mild ACR improved with steroids. One presented steroid-resistant severe rejection, improved after rabbit anti-thymocyte globulin (r-ATG), but unfortunately died for encephalitis caused by opportunistic infections.
Collapse
Affiliation(s)
- E Y Yoshitoshi
- Department of Hepatobiliary, Pancreas, Transplantation and Pediatric Surgery, Kyoto University Hospital, Graduate School of Medicine, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto city, 606-8507, Japan.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
83
|
Hasegawa T, Oda K, Sato Y, Ito H, Masuda S, Yamada T, Matsumoto M, Murayama H, Takei H. Microfocus x-ray imaging of traceable pointlike (22)Na sources for quality control. Med Phys 2012; 39:4414-22. [PMID: 22830774 DOI: 10.1118/1.4730293] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE The purpose of this study is to propose a microfocus x-ray imaging technique for observing the internal structure of small radioactive sources and evaluating geometrical errors quantitatively, and to apply this technique to traceable pointlike (22)Na sources, which were designed for positron emission tomography calibration, for the purpose of quality control of the pointlike sources. METHODS A microfocus x-ray imaging system with a focus size of 0.001 mm was used to obtain projection x-ray images and x-ray CT images of five pointlike source samples, which were manufactured during 2009-2012. The obtained projection and tomographic images were used to observe the internal structure and evaluate geometrical errors quantitatively. Monte Carlo simulation was used to evaluate the effect of possible geometrical errors on the intensity and uniformity of 0.511 MeV annihilation photon pairs emitted from the sources. RESULTS Geometrical errors were evaluated with sufficient precision using projection x-ray images. CT images were used for observing the internal structure intuitively. As a result, four of the five examined samples were within the tolerance to maintain the total uncertainty below ±0.5%, given the source radioactivity; however, one sample was found to be defective. CONCLUSIONS This quality control procedure is crucial and offers an important basis for using the pointlike (22)Na source as a basic calibration tool. The microfocus x-ray imaging approach is a promising technique for visual and quantitative evaluation of the internal geometry of small radioactive sources.
Collapse
Affiliation(s)
- T Hasegawa
- Allied Health Sciences, Kitasato University, Kanagawa, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
84
|
Matsunaga T, Mutai H, Kunishima S, Namba K, Morimoto N, Shinjo Y, Arimoto Y, Kataoka Y, Shintani T, Morita N, Sugiuchi T, Masuda S, Nakano A, Taiji H, Kaga K. A prevalent founder mutation and genotype-phenotype correlations ofOTOFin Japanese patients with auditory neuropathy. Clin Genet 2012; 82:425-32. [DOI: 10.1111/j.1399-0004.2012.01897.x] [Citation(s) in RCA: 56] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
85
|
Hayashi K, Masuda S, Kimura H. Analyzing global trends of biomarker use in drug interventional clinical studies. Drug Discov Ther 2012; 6:102-107. [PMID: 22622020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
The trend of biomarker use in drug interventional clinical studies was analyzed using ClinicalTrials.gov to provide an overview of how biomarkers are used to streamline clinical studies and to examine regional differences. A total of 3,383 clinical study data was analyzed according to phase, region, sponsor, and therapeutic class. The number of clinical studies using biomarkers has been increasing constantly and is dependent on the number of Phase I and II studies. The majority of studies (58.5%) were sponsored by the United States, with the studies being conducted mainly in the sponsor's home region (80.3%). The use of biomarkers was prominent in the oncology area (37.1%). Although current data indicates some bias in the clinical use of biomarkers, it is expected that their use will increase in later phase studies or other therapeutic areas as biomarker development proceeds. In addition, limited regional use of biomarkers may lead to differences in biomarker use in drug development and in combination with political support may result in differences in competitiveness of drug development. Biomarkers would be a powerful tool against deteriorating research and development productivity when used more in appropriate clinical study conditions.
Collapse
Affiliation(s)
- K Hayashi
- Graduate School of Pharmaceutical Science, The University of Tokyo, Tokyo, Japan.
| | | | | |
Collapse
|
86
|
Kawabata-Shoda E, Masuda S, Kimura H. Anticancer drug development from traditional cytotoxic to targeted therapies: evidence of shorter drug research and development time, and shorter drug lag in Japan. J Clin Pharm Ther 2012; 37:547-52. [PMID: 22428857 DOI: 10.1111/j.1365-2710.2012.01332.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
WHAT IS KNOWN AND OBJECTIVE Concern about the drug lag, the delay in marketing approval between one country and another, for anticancer drugs has increased in Japan. Although a number of studies have investigated the drug lag, none has investigated it in relation to the transition of anticancer therapy from traditional cytotoxic drugs to molecularly targeted agents. Our aim was to investigate current trend in oncology drug lag between the US and Japan and identify oncology drugs approved in only one of the two countries. METHODS Publicly and commercially available data sources were used to identify drugs approved in the US and Japan as of 31 December 2010 and the data used to calculate the drug lag for individual drugs. RESULTS AND DISCUSSION Fifty-one drugs were approved in both the US and Japan, whereas 34 and 19 drugs were approved only in the US or Japan, respectively. Of the 19 drugs approved only in Japan, 12 had not been subject to development for a cancer indication in the US, and all were approved before 1996 in Japan. Of the 34 drugs approved only in the US, 20 had not been subject to development in Japan, and none was in the top 25 by annual US anticancer drug-class sales. For drugs approved in both countries, the mean approval lag of the molecularly targeted drugs (MTDs) was significantly shorter than that of the non-molecularly targeted drugs (non-MTDs) (3·3 vs. 5·4 years). Further, mean R&D time of the MTDs was significantly shorter than that of non-MTDs (10·0 vs. 13·7 years). The price of MTDs had increased on average by 6·6% annually in the US, whereas it had decreased on average by 4·3% biyearly in Japan. WHAT IS NEW AND CONCLUSION The emergence of new molecularly targeted agents has contributed to reducing the approval lag, most likely due to improvements in R&D strategy.
Collapse
Affiliation(s)
- E Kawabata-Shoda
- Pharmaco-Business Innovation Laboratory, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan
| | | | | |
Collapse
|
87
|
Zhang C, McFarlane C, Lokireddy S, Masuda S, Ge X, Gluckman PD, Sharma M, Kambadur R. Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia 2012; 55:183-93. [PMID: 21927895 DOI: 10.1007/s00125-011-2304-4] [Citation(s) in RCA: 140] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/04/2011] [Accepted: 07/29/2011] [Indexed: 01/22/2023]
Abstract
AIMS/HYPOTHESIS Although myostatin-null (Mstn (-/-)) mice fail to accumulate fat in adipose tissue when fed a high-fat diet (HFD), little is known about the molecular mechanism(s) behind this phenomenon. We therefore sought to identify the signalling pathways through which myostatin regulates accumulation and/or utilisation of fat. METHODS Wild-type, Mstn (-/-) and wild-type mice treated with soluble activin type IIB receptor (sActRIIB) were fed a control chow diet or an HFD for 12 weeks. Changes in gene expression were measured by microarray and quantitative PCR. Histological changes in white adipose tissue were assessed together with peripheral tissue fatty acid oxidation and changes in circulating hormones following HFD feeding. RESULTS Our results demonstrate that inactivation of myostatin results in reduced fat accumulation in mice on an HFD. Molecular analysis revealed that metabolic benefits, due to lack of myostatin, are mediated through at least two independent mechanisms. First, lack of myostatin increased fatty acid oxidation in peripheral tissues through induction of enzymes involved in lipolysis and in fatty acid oxidation in mitochondria. Second, inactivation of myostatin also enhanced brown adipose formation in white adipose tissue of Mstn (-/-) mice. Consistent with the above, treatment of HFD-fed wild-type mice with the myostatin antagonist, sActRIIB, reduced the obesity phenotype. CONCLUSIONS/INTERPRETATION We conclude that absence of myostatin results in enhanced peripheral tissue fatty acid oxidation and increased thermogenesis, culminating in increased fat utilisation and reduced adipose tissue mass. Taken together, our data suggest that anti-myostatin therapeutics could be beneficial in alleviating obesity.
Collapse
MESH Headings
- Activin Receptors, Type II/chemistry
- Activin Receptors, Type II/therapeutic use
- Adipose Tissue, Brown/drug effects
- Adipose Tissue, Brown/metabolism
- Adipose Tissue, Brown/pathology
- Adiposity/drug effects
- Animals
- Anti-Obesity Agents/chemistry
- Anti-Obesity Agents/therapeutic use
- Diet, High-Fat/adverse effects
- Fatty Acids/metabolism
- Gene Expression Profiling
- Gene Expression Regulation/drug effects
- Lipolysis/drug effects
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Molecular Targeted Therapy
- Muscle Proteins/genetics
- Muscle Proteins/metabolism
- Muscle, Skeletal/drug effects
- Muscle, Skeletal/metabolism
- Myostatin/antagonists & inhibitors
- Myostatin/genetics
- Myostatin/metabolism
- Obesity/etiology
- Obesity/metabolism
- Obesity/pathology
- Obesity/prevention & control
- Oxidation-Reduction/drug effects
- RNA, Messenger/metabolism
- Solubility
Collapse
Affiliation(s)
- C Zhang
- Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A*STAR), Brenner Centre for Molecular Medicine, Singapore, Republic of Singapore
| | | | | | | | | | | | | | | |
Collapse
|
88
|
Masuda S. Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer. Ann Oncol 2011; 22:2533-2534. [DOI: 10.1093/annonc/mdr307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
89
|
Masuda S, Kada E, Nagao M, Sasaki R. In vitro neuroprotective action of recombinant rat erythropoietin produced by astrocyte cell lines and comparative studies with erythropoietin produced by Chinese hamster ovary cells. Cytotechnology 2011; 29:207-13. [PMID: 19003343 DOI: 10.1023/a:1008014206833] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
In the central nervous system, astrocytes produce erythropoietin (Epo) and neurons express its receptor. To examine whether or not the brain Epo protects the in vitro cultured neurons from glutamate-induced cell death, we established rat astrocyte cell lines containing the plasmid for production of recombinant rat Epo. Epo partially purified from the culture medium showed a neuroprotective effect similar to that of rat Epo produced by Chinese hamster ovary (CHO) cells. Comparison was made in some other properties between Epo produced by these astrocyte cell lines and that by CHO cells. Digestion of Epo with glycosidases indicated that there was a little difference in glycosylation of Epo produced by two types of the cells.
Collapse
Affiliation(s)
- S Masuda
- Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan
| | | | | | | |
Collapse
|
90
|
Zhang C, McFarlane C, Lokireddy S, Bonala S, Ge X, Masuda S, Gluckman PD, Sharma M, Kambadur R. Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway. Diabetologia 2011; 54:1491-501. [PMID: 21347623 DOI: 10.1007/s00125-011-2079-7] [Citation(s) in RCA: 106] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/21/2010] [Accepted: 01/18/2011] [Indexed: 12/18/2022]
Abstract
AIMS/HYPOTHESIS Myostatin-null mice (Mstn(-/-)) have reduced body fat and increased tolerance to glucose. To date the molecular mechanisms through which myostatin regulates body fat content and insulin sensitivity are not known. Therefore, the aim of the current study was to identify signalling pathways through which myostatin regulates insulin sensitivity. METHODS Wild-type (WT) mice and Mstn(-/-) mice were fed either a control chow diet or a high fat diet (HFD) for 12 weeks. Glucose tolerance testing and insulin stimulated glucose uptake by M. extensor digitorum longus (EDL) were used as variables to determine insulin sensitivity. Quantitative PCR, Western blotting and enzyme assays were used to monitor AMP-activated protein kinase (AMPK) levels and activity. RESULTS Mstn(-/-) mice exhibited reduced fat accumulation and peripheral insulin resistance when compared with WT mice, even when they were fed an HFD. Furthermore, treatment with a myostatin antagonist also increased insulin sensitivity during HFD. Consistent with increased insulin sensitivity, we also detected elevated levels of GLUT4, AKT, p-AKT and insulin receptor substrate-1 in Mstn(-/-) muscles. Molecular analysis showed that there is increased expression and activity of AMPK in Mstn(-/-) muscles. Furthermore, we also observed an increase in the AMPK downstream target genes, Sirt1 and Pgc-1α (also known as Ppargc1a), in skeletal muscle of Mstn(-/-) mice. CONCLUSIONS/INTERPRETATION We conclude that myostatin inactivation leads to increased AMPK levels and activity resulting in increased insulin sensitivity of skeletal muscle. We propose that, by regulating AMPK in skeletal muscle and adipose tissues, myostatin plays a major role in regulating insulin signalling.
Collapse
Affiliation(s)
- C Zhang
- Development and Metabolism Program, Singapore Institute for Clinical Sciences, Singapore, Republic of Singapore
| | | | | | | | | | | | | | | | | |
Collapse
|
91
|
Egawa T, Hamada T, Ma X, Karaike K, Kameda N, Masuda S, Iwanaka N, Hayashi T. Caffeine activates preferentially α1-isoform of 5'AMP-activated protein kinase in rat skeletal muscle. Acta Physiol (Oxf) 2011; 201:227-38. [PMID: 21241457 DOI: 10.1111/j.1748-1716.2010.02169.x] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
AIM Caffeine activates 5'AMP-activated protein kinase (AMPK), a signalling intermediary implicated in the regulation of glucose, lipid and energy metabolism in skeletal muscle. Skeletal muscle expresses two catalytic α subunits of AMPK, α1 and α2, but the isoform specificity of caffeine-induced AMPK activation is unclear. The aim of this study was to determine which α isoform is preferentially activated by caffeine in vitro and in vivo using rat skeletal muscle. METHODS Rat epitrochlearis muscle was isolated and incubated in vitro in the absence or presence of caffeine. In another experiment, the muscle was dissected after intravenous injection of caffeine. Isoform-specific AMPK activity, the phosphorylation status of AMPKα Thr(172) and acetyl-CoA carboxylase (ACC) Ser(79) , the concentrations of ATP, phosphocreatine (PCr) and glycogen, and 3-O-methyl-d-glucose (3MG) transport activity were estimated. RESULTS Incubation of isolated epitrochlearis muscle with 1 mm of caffeine for 15 min increased AMPKα1 activity, but not AMPKα2 activity; concentrations of ATP, PCr and glycogen were not affected. Incubation with 3 mm of caffeine activated AMPKα2 and reduced PCr and glycogen concentrations. Incubation with 1 mm of caffeine increased the phosphorylation of AMPK and ACC and enhanced 3MG transport. Intravenous injection of caffeine (5 mg kg(-1) ) predominantly activated AMPKα1 and increased 3MG transport without affecting energy status. CONCLUSION Our results suggest that of the two α isoforms of AMPK, AMPKα1 is predominantly activated by caffeine via an energy-independent mechanism and that the activation of AMPKα1 increases glucose transport and ACC phosphorylation in skeletal muscle.
Collapse
Affiliation(s)
- T Egawa
- Laboratory of Sports and Exercise Medicine, Graduate School of Human and Environmental Studies, Kyoto University, Kyoto, Japan
| | | | | | | | | | | | | | | |
Collapse
|
92
|
Sogo M, Sakamoto Y, Aoki M, Masuda S. Potassium-benzene interactions on Pt(111) studied by metastable atom electron spectroscopy. J Chem Phys 2010; 133:134704. [PMID: 20942552 DOI: 10.1063/1.3482849] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023] Open
Abstract
Electron emission spectra obtained by thermal collisions of He(∗)(2(3)S) metastable atoms with C(6)H(6)/Pt(111), C(6)H(6)/K/Pt(111), and K/C(6)H(6)/Pt(111) were measured in the temperature range of 50-200 K to elucidate the adsorption/aggregation states, thermal stabilities of pure and binary films, and local electronic properties at the organic-metal interface. For C(6)H(6)/Pt(111), the He(∗)(2(3)S) atoms de-excite on the chemisorbed overlayer predominantly via resonance ionization followed by Auger neutralization and partly via Penning ionization (PI) yielding weak emission just below the Fermi level (E(F)). We assigned this emission to the C(6)H(6) π-derived states delocalized over the Pt 5d bands on the basis of recent density functional calculations. During the layer-by-layer growth, the C(6)H(6)-derived bands via PI reveal a characteristic shift caused by the final-state effect (hole response at the topmost layer). C(6)H(6) molecules chemisorb weakly on the bimetallic Pt(111) (θ(K)=0.1) and physisorb on the K multilayer. In both cases, the sum rule was found to be valid between the K 4s and C(6)H(6)-derived bands. The band intensity versus exposure plot indicates that the C(6)H(6) film grows on the K multilayer by the Volmer-Weber mechanism (island growth), reflecting the weak K-C(6)H(6) interactions. In case of K/C(6)H(6)/Pt(111), the K atoms are trapped on the topmost C(6)H(6) layer at 65 K, forming particlelike clusters. The surface plasmon satellite was identified for the first time and the loss energy increases with increasing cluster size. The K clusters are unstable above ∼100 K due to thermal migration into the C(6)H(6) film. When the cluster coverage is low, the K 4s band extends below and above E(F) of the Pt substrate and the anomaly is discussed in terms of vacuum level bending around the cluster.
Collapse
Affiliation(s)
- M Sogo
- Department of Basic Science, Graduate School of Arts and Sciences, The University of Tokyo, Komaba, Meguro, Tokyo 153-8902, Japan
| | | | | | | |
Collapse
|
93
|
Tsujii T, Masuda S, Sakatani K, Akiyama T, Watanabe S. P20-21 A functional role of the inferior frontal cortex in belief-bias syllogistic reasoning: an rTMS study. Clin Neurophysiol 2010. [DOI: 10.1016/s1388-2457(10)60918-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
94
|
Uzawa A, Mori M, Hayakawa S, Masuda S, Kuwabara S. Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis. Eur J Neurol 2009; 17:672-6. [PMID: 20039942 DOI: 10.1111/j.1468-1331.2009.02897.x] [Citation(s) in RCA: 80] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
BACKGROUND Although the benefit of treatment for relapsing-remitting multiple sclerosis (MS) is firmly established, whether interferon beta-1b (IFNB-1b) therapy is efficacious for neuromyelitis optica (NMO) has been debated. METHODS We reviewed the responses to IFNB-1b treatment in 18 patients with relapsing NMO and compared the results with those from 38 patients with relapsing-remitting MS. We compared clinical characteristics, the annualized relapse rate (ARR) and the probability of being relapse free before and after IFNB-1b treatment in patients with NMO and MS. RESULTS The proportion of patients with more than 50% increase in the ARR after IFNB-1b treatment was much higher in NMO than in MS (P = 0.046). ARR was significantly lower in patients with MS after IFNB-1b administration than before (P = 0.015), but not in NMO. Kaplan-Meier and log-rank statistical analyses revealed that relapse-free rates were lower in NMO than MS after IFNB-1b treatment (P = 0.032). The analyses also showed lower relapse-free rates during the pre-IFNB-1b treatment period than the post-IFNB-1b treatment period in MS (P < 0.001), but not in NMO. CONCLUSION IFNB-1b treatment does not appear to be effective for preventing relapse in NMO likely because of differences between the immune-pathogenesis of NMO and MS.
Collapse
Affiliation(s)
- A Uzawa
- Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
| | | | | | | | | |
Collapse
|
95
|
Saito H, Oshima M, Kiuchi R, Watanabe K, Kitagawa K, Masuda S. [Relationship between pleural indentation on computed tomography scans and pleural invasion in small peripheral lung cancer of 2 cm in size or less]. Kyobu Geka 2009; 62:767-772. [PMID: 19670775] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Eighty-six cases of small peripheral lung cancer without contact with the chest wall on computed tomography (CT) scans were studied on the presence of radiological pleural indentation and pathological pleural invasion. Twenty-three tumors in 44 cases with pleural indentation were found to reach the pleura histologically, but only one in 42 cases without pleural indentation. There is a high possibility of pleural invasion or contact with the pleura in small lung cancers with pleural indentation. There was no relationship between the presence of pleural indentation and the tumor/chest wall distance on CT scans. Pleural indentations were more frequently seen in small adenocarcinomas of low ground-glass opacity (GGO) ratio or Noguchi's type C. Small lung nodules with pleural indentation had better be removed as early as possible because of the possibility of pleural invasion and pleural dissemination.
Collapse
Affiliation(s)
- H Saito
- Department of Thoracic Surgery, Koseiren Takaoka Hospital, Takaoka, Japan
| | | | | | | | | | | |
Collapse
|
96
|
Masuda S, Hayashi T, Hashimoto T, Taguchi S. Correlation of dystrophin-glycoprotein complex and focal adhesion complex with myosin heavy chain isoforms in rat skeletal muscle. Acta Physiol (Oxf) 2009; 195:483-94. [PMID: 19040708 DOI: 10.1111/j.1748-1716.2008.01944.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
AIM The dystrophin-glycoprotein complex (DGC) and focal adhesion complex (FAC) are transmembrane structures in muscle fibres that link the intracellular cytoskeleton to the extracellular matrix. DGC and FAC proteins are abundant in slow-type muscles, indicating the structural reinforcement which play a pivotal role in continuous force output to maintain posture for long periods. The aim of the present study was to examine the expression of these structures across fast-type muscles containing different myosin heavy chain (MHC) isoform patterns which reflect the fatigue-resistant characteristics of skeletal muscle. METHODS We measured the expression of dystrophin and beta1 integrin (representative proteins of DGC and FAC respectively) in plantaris, extensor digitorum longus, tibialis anterior, red and white portions of gastrocnemius, superficial portion of vastus lateralis and diaphragm, in comparison with soleus (SOL) and cardiac muscle from rats. RESULTS The expression of dystrophin and beta1 integrin correlated positively with the percentage of type I, IIa and IIx MHC isoforms and negatively with that of type IIb MHC isoform in fast-type skeletal muscles, and their expression was abundant in SOL and cardiac muscle. CONCLUSION Our results support the idea that DGC and FAC are among the factors that explain the fatigue-resistant property not only of slow-type but also of fast-type skeletal muscles.
Collapse
|
97
|
Ohwada C, Nakaseko C, Sakai S, Takeda Y, Abe D, Takeuchi M, Sakaida E, Masuda S, Shimizu N, Cho R, Nishimura M, Kanai K, Misawa S, Kuwabara S. Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome. Bone Marrow Transplant 2008; 43:739-40. [DOI: 10.1038/bmt.2008.381] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
98
|
Tabayashi K, Motoyoshi N, Saiki Y, Kokubo H, Takahashi G, Masuda S, Shibuya T, Akasaka J, Oda K, Kamata M, Iguti A. Efficacy of perfusion cooling of the epidural space and cerebrospinal fluid drainage during repair of extent I and II thoracoabdominal aneurysm. J Cardiovasc Surg (Torino) 2008; 49:749-755. [PMID: 19043389] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
AIM The aim of this study was to evaluate spinal cord injury and mortality resulting from repair of extent I and II thoracoabdominal aneurysm. The authors compared patients operated under mild hypothermia with or without epidural perfusion cooling (EPC) and cerebrospinal fluid drainage (CSFD). METHODS From 1988 to 2007, 116 patients underwent replacement of the thoracoabdominal aorta; the procedure was performed in 38 patients with the aid of mild hypothermia alone (group A), and in 78 patients with the aid of EPC, mild hypothermia and CSFD (group B). Two catheters for epidural perfusion cooling were inserted in group B, in which one catheter was inserted into the epidural space to infuse chilled saline, and the other was inserted into the subdural space to drain the cerebrospinal fluid and to measure temperature and pressure. There were no significant differences in mean age, etiology of aortic disease, and aneurysm extent between the two groups. RESULTS There were no significant differences in cardiopulmonary bypass time, the lowest nasopharyngeal temperature and operation time between the two study groups. The incidence of spinal cord injury in group A (16.2%) was significantly higher than in group B (3.8%, P=0.03). Hospital mortality in groups A and B was 10.5% and 2.6%, respectively (P=0.08). There was no significant difference in postoperative complications between the two study groups. CONCLUSION The combination of EPC and CSFD was effective in lowering the incidence of postoperative spinal cord injury in the repair of extent I and II thoracoabdominal aortic aneurysm.
Collapse
Affiliation(s)
- K Tabayashi
- Department of Cardiovascular Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
99
|
Saito T, Tanoi K, Matsue H, Iikura H, Hamada Y, Seyama S, Masuda S, Nakanishi TM. Application of prompt gamma-ray analysis and instrumental neutron activation analysis to identify the beef production distinct. J Radioanal Nucl Chem 2008. [DOI: 10.1007/s10967-008-0810-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
100
|
Masuda S, Miura E, Koyama K, Kato S. Absolute calibration of an electron spectrometer using high energy electrons produced by the laser-plasma interaction. Rev Sci Instrum 2008; 79:083301. [PMID: 19044340 DOI: 10.1063/1.2969655] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
An in situ observation system has been developed to observe the absolute electron energy spectra of electron beams generated by laser-plasma interaction. A phosphor screen (DRZ) coupled with a charge coupled device camera is used to detect the electrons. A new method is proposed to calibrate the absolute sensitivity of the detection system for a wide energy range with a single shot by using an electron beam generated by laser-plasma interaction. The sensitivity of the system is found to be high, which is comparable to that of an imaging plate.
Collapse
Affiliation(s)
- S Masuda
- National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba Central 2, 1-1-1 Umezono, Tsukuba, Ibaraki 305-8568, Japan
| | | | | | | |
Collapse
|